SAN DIEGO--(BUSINESS WIRE)--n-Lorem, a nonprofit foundation, announced today the publication of an article in the journal Nucleic Acid Therapeutics that explores potential regulatory approaches that ...
Hereditary hemoglobinopathies, including quantitative abnormalities (thalassemia) and qualitative abnormalities (structural hemoglobin variants), cause abnormal Hb structure 1. Beta (β)-thalassemia is ...
Chromosomal Microarray Analysis (CMA) is currently the test of choice in patients with neurodevelopmental disorders and/or congenital anomalies, as well as in fetuses with structural aberrations [1].